Blue Trust’s Beta Bionics BBNX Stock Holding History
Bought
Maintained
Sold
Other funds holding BBNX
Blue Trust's BBNX Position: Q3 2026 in Review
Blue Trust reduced its Beta Bionics (BBNX) stake by 11% in Q3 2026, selling an estimated $90 and leaving 42 shares worth $797. The position accounts for ﹤0.01% of the portfolio, ranked #2209.
Blue Trust first reported a position in BBNX in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.43K in Q4 2025. 106 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.
- Blue Trust held 42 shares of Beta Bionics worth $797 as of Q3 2026.
- Blue Trust sold 5 Beta Bionics shares in Q3 2026, an estimated $90.
- Beta Bionics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2209 holding.
- Blue Trust first reported a position in Beta Bionics in Q2 2025 and has held it in 6 quarters since.
- Blue Trust's Beta Bionics position peaked at $1.43K in Q4 2025.
- 106 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.